LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC recalls REVOLVE ADVANCED ADIPOSE SYSTEM, for aspiration, harvesting, filtering, and transferring of autologous adipose tissue f…
- Recall date
- August 8, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0823-2018
- FDA classification
- Class II
- Brand / firm
- LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC
- Sold / distributed
- US Nationwide, Canada, Australia, Chile, Brazil, Israel, Japan New Zealand & Singapore
Why it was recalled
Presence of bacterial endotoxins levels above the acceptable limit
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
REVOLVE ADVANCED ADIPOSE SYSTEM, for aspiration, harvesting, filtering, and transferring of autologous adipose tissue for aesthetic body contouring.
Get recall alerts
Free email alert whenever LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC